2,052 Shares in Welltower Inc. $WELL Acquired by MMA Asset Management LLC

MMA Asset Management LLC purchased a new stake in shares of Welltower Inc. (NYSE:WELL) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,052 shares of the real estate investment trust’s stock, valued at approximately $472,000.

A number of other large investors have also recently modified their holdings of WELL. Collaborative Fund Advisors LLC increased its holdings in Welltower by 33.5% during the 3rd quarter. Collaborative Fund Advisors LLC now owns 1,436 shares of the real estate investment trust’s stock worth $331,000 after purchasing an additional 360 shares during the period. Pathway Financial Advisers LLC bought a new stake in Welltower during the 3rd quarter valued at $168,000. Kestra Private Wealth Services LLC lifted its holdings in shares of Welltower by 0.4% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 41,459 shares of the real estate investment trust’s stock worth $9,545,000 after buying an additional 178 shares during the period. Northeast Investment Management lifted its holdings in shares of Welltower by 110.7% in the 3rd quarter. Northeast Investment Management now owns 48,505 shares of the real estate investment trust’s stock worth $11,168,000 after buying an additional 25,489 shares during the period. Finally, Chicago Partners Investment Group LLC lifted its holdings in shares of Welltower by 21.4% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 2,360 shares of the real estate investment trust’s stock worth $560,000 after buying an additional 416 shares during the period. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Insider Activity at Welltower

In related news, Director Andrew Gundlach acquired 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the purchase, the director directly owned 30,000 shares of the company’s stock, valued at $7,261,800. This trade represents a 20.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. Insiders own 0.37% of the company’s stock.

Welltower Stock Performance

Shares of NYSE:WELL opened at $245.78 on Friday. The company has a market capitalization of $180.30 billion, a price-to-earnings ratio of 106.40, a price-to-earnings-growth ratio of 1.18 and a beta of 0.79. Welltower Inc. has a 52 week low of $181.47 and a 52 week high of $255.20. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.39. The firm has a 50 day moving average of $233.72 and a 200 day moving average of $219.33.

Welltower (NYSE:WELL) last posted its earnings results on Monday, October 26th. The real estate investment trust reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.03. The company had revenue of $3.72 billion during the quarter, compared to analyst estimates of $3.64 billion. Welltower had a return on equity of 3.61% and a net margin of 12.08%. Welltower’s revenue was up 38.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.34 earnings per share. On average, sell-side analysts predict that Welltower Inc. will post 6.51 earnings per share for the current fiscal year.

Welltower Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 19th. Stockholders of record on Tuesday, November 10th will be given a $0.85 dividend. This represents a $3.40 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Tuesday, November 10th. Welltower’s payout ratio is presently 147.19%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on WELL. JPMorgan Chase & Co. raised Welltower from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $230.00 to $260.00 in a research report on Thursday, September 24th. BMO Capital Markets lifted their price objective on Welltower from $245.00 to $265.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Scotiabank lifted their price objective on Welltower from $244.00 to $251.00 and gave the company an “outperform” rating in a report on Wednesday, September 2nd. KeyCorp upped their price objective on shares of Welltower from $240.00 to $275.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 4th. Finally, BNP Paribas Exane increased their target price on shares of Welltower from $238.00 to $272.00 and gave the stock an “outperform” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Welltower currently has a consensus rating of “Moderate Buy” and an average price target of $259.81.

Welltower Company Profile

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.